Charlotte practices complex patent litigation concerning biotechnology, pharmaceuticals, and the chemicals arts, with an emphasis on litigation under the Hatch-Waxman Act. She has litigated cases concerning anti-cancer drugs, oral contraceptives, immunosuppressants, and drugs for treating high cholesterol, chronic kidney disease, Alzheimer’s disease, and Parkinson’s disease, including as lead trial counsel. Additionally, she has experience arguing before the United States Court of Appeals for the Federal Circuit and in inter partes review proceedings before the Patent Trial and Appeal Board, as well as in litigation pertaining to patent inventorship and arbitration before the ICC International Court of Arbitration.
Prior to joining the firm, Charlotte practiced as a barrister in the UK where she was involved in high value and technically complex patent litigations, including an appeal to the House of Lords, the highest court in the UK. Charlotte has also worked on patent Oppositions before the European Patent Office.
While at Law School, she received several scholarships from the Honourable Society of Lincoln’s Inn and was the winner of the Lincoln’s Inn Annual Debating Shield. During her M.Sc, Charlotte was awarded the British Academy of Forensic Science National Project Prize for her research into the use of DNA profiling of bears as a tool to combat illegal poaching in British Columbia, Canada.
Novartis Pharmaceuticals Corporation et al v. Noven Pharmaceuticals Inc.
D. Del. (2015)
Charlotte secured an affirmance by the Federal Circuit in a Hatch-Waxman litigation concerning Novartis’s Exelon® Transdermal Patches for the treatment of Alzheimer’s Disease. The Federal Circuit agreed that because the stability problem was not known, one of ordinary skill would not have been motivated to fix it.